Muramyl dipeptide

CAT:
804-HY-127090-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Muramyl dipeptide - image 1

Muramyl dipeptide

  • Description :

    Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. Muramyl dipeptide is an inducer of bone formation through induction of Runx2. Muramyl dipeptide directly enhances osteoblast differentiation by up-regulating Runx2 gene expression through MAPK pathways. Muramyl dipeptide is a NLRP1 agonist[1][2].
  • Product Name Alternative :

    MDP
  • UNSPSC :

    12352211
  • Hazard Statement :

    H315, H319
  • Target :

    NOD-like Receptor (NLR) ; p38 MAPK
  • Type :

    Reference compound
  • Related Pathways :

    Immunology/Inflammation; MAPK/ERK Pathway
  • Applications :

    COVID-19-immunoregulation
  • Field of Research :

    Inflammation/Immunology; Cancer
  • Assay Protocol :

    https://www.medchemexpress.com/muramyl-dipeptide.html
  • Concentration :

    10mM
  • Purity :

    98.0
  • Solubility :

    DMSO : 100 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic)
  • Smiles :

    CC(N[C@@H](C=O)[C@H]([C@H](O)[C@H](O)CO)O[C@H](C)C(N[C@@H](C)C(N[C@@H](C(N)=O)CCC(O)=O)=O)=O)=O
  • Molecular Formula :

    C19H32N4O11
  • Molecular Weight :

    492.48
  • Precautions :

    H315, H319
  • References & Citations :

    [1]Park OJ, et al. Muramyl Dipeptide, a Shared Structural Motif of Peptidoglycans, Is a Novel Inducer of Bone Formation through Induction of Runx2. J Bone Miner Res. 2017 Jul;32 (7) :1455-1468.|[2]V Kaushal, et al. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation. Cell Death Differ. 2015 Oct;22 (10) :1676-86.
  • Shipping Conditions :

    Blue Ice
  • Storage Conditions :

    -20°C, 3 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Phase 3
  • Isoform :

    NLRP1; p38 MAPK
  • CAS Number :

    [53678-77-6]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide